Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Peptides for Body Recomposition: Protocol Comparison

The table below compares the most effective peptide protocols for body recomposition based on mechanism, dosing logistics, and expected outcomes over a 12-week cycle. CJC-1295/Ipamorelin GHRH/GHRP synergy. Pulsatile GH/IGF-1 elevation 200–300mcg each, SubQ, ni

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • The table below compares the most effective peptide protocols for body recomposition based on mechanism, dosing logistics, and expected outcomes over a 12-week cycle.
  • CJC-1295/Ipamorelin
  • GHRH/GHRP synergy. Pulsatile GH/IGF-1 elevation
  • 200–300mcg each, SubQ, nightly
  • +1.5–3kg lean mass, −2–4kg fat mass
  • Neutral to mild increase
  • Gold standard for balanced recomposition. Mimics natural GH physiology with minimal side effects
  • MK-677 (Ibutamoren)
  • Oral ghrelin mimetic. Sustained 24hr GH/IGF-1 elevation
  • 15–25mg oral, once daily
  • +1–2kg lean mass, −1–3kg fat mass
  • Significant increase (60–70% of users)
  • Convenient but appetite stimulation makes caloric control difficult. Best for lean bulking rather than pure recomposition
  • Tesamorelin
  • Selective GHRH analog. Targets visceral adipose tissue
  • 2mg SubQ daily
  • +0.5–1.5kg lean mass, −2–5kg visceral fat
  • Neutral
  • Best choice for individuals with elevated waist circumference and metabolic dysfunction. Precise, predictable
  • AOD-9604
  • GH fragment. Lipolysis without GH receptor activation
  • 250–500mcg SubQ daily fasted
  • Minimal lean mass change, −1–2kg fat mass
  • Pure fat-loss agent with no systemic effects. Ideal for final cut phase or stacking with anabolic peptides
  • MOTS-c
  • Mitochondrial peptide. AMPK activation, insulin sensitization
  • 5–10mg SubQ 2–3×/week
  • Minimal lean mass change, −1–3kg fat mass
  • Long-term metabolic optimizer. Improves nutrient partitioning and insulin sensitivity over months
  • Tesofensine
  • Triple monoamine reuptake inhibitor. Thermogenesis + appetite suppression
  • 0.25–0.5mg oral daily
  • Minimal lean mass change, −4–7kg fat mass
  • Strong decrease
  • Most potent fat-loss agent available. Requires cardiovascular screening, stimulant profile limits tolerability
  • BPC-157 + TB-500
  • Tissue repair, angiogenesis, anti-inflammatory signaling
  • BPC-157: 250–500mcg daily; TB-500: 2–5mg 2×/week
  • No direct body composition effect
  • Enables training consistency and volume. Indirect but essential for recomposition success